rs2717482

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001378609.3(OTOGL):​c.6456G>A​(p.Thr2152Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.93 in 1,487,130 control chromosomes in the GnomAD database, including 644,104 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T2152T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.95 ( 68545 hom., cov: 32)
Exomes 𝑓: 0.93 ( 575559 hom. )

Consequence

OTOGL
NM_001378609.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.841

Publications

18 publications found
Variant links:
Genes affected
OTOGL (HGNC:26901): (otogelin like) The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012]
OTOGL Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 84B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.019).
BP6
Variant 12-80367685-G-A is Benign according to our data. Variant chr12-80367685-G-A is described in ClinVar as Benign. ClinVar VariationId is 226970.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.841 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.977 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGLNM_001378609.3 linkc.6456G>A p.Thr2152Thr synonymous_variant Exon 54 of 59 ENST00000547103.7 NP_001365538.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGLENST00000547103.7 linkc.6456G>A p.Thr2152Thr synonymous_variant Exon 54 of 59 5 NM_001378609.3 ENSP00000447211.2 Q3ZCN5

Frequencies

GnomAD3 genomes
AF:
0.948
AC:
144249
AN:
152094
Hom.:
68493
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.982
Gnomad AMI
AF:
0.940
Gnomad AMR
AF:
0.944
Gnomad ASJ
AF:
0.910
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.947
Gnomad FIN
AF:
0.973
Gnomad MID
AF:
0.854
Gnomad NFE
AF:
0.924
Gnomad OTH
AF:
0.938
GnomAD2 exomes
AF:
0.942
AC:
133550
AN:
141818
AF XY:
0.938
show subpopulations
Gnomad AFR exome
AF:
0.984
Gnomad AMR exome
AF:
0.955
Gnomad ASJ exome
AF:
0.895
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.970
Gnomad NFE exome
AF:
0.918
Gnomad OTH exome
AF:
0.921
GnomAD4 exome
AF:
0.928
AC:
1239245
AN:
1334918
Hom.:
575559
Cov.:
35
AF XY:
0.928
AC XY:
613494
AN XY:
660958
show subpopulations
African (AFR)
AF:
0.983
AC:
26943
AN:
27410
American (AMR)
AF:
0.953
AC:
23886
AN:
25052
Ashkenazi Jewish (ASJ)
AF:
0.903
AC:
18784
AN:
20794
East Asian (EAS)
AF:
1.00
AC:
35196
AN:
35202
South Asian (SAS)
AF:
0.947
AC:
64969
AN:
68594
European-Finnish (FIN)
AF:
0.970
AC:
48294
AN:
49776
Middle Eastern (MID)
AF:
0.857
AC:
4564
AN:
5326
European-Non Finnish (NFE)
AF:
0.921
AC:
965348
AN:
1047702
Other (OTH)
AF:
0.931
AC:
51261
AN:
55062
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
4064
8128
12191
16255
20319
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20684
41368
62052
82736
103420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.948
AC:
144358
AN:
152212
Hom.:
68545
Cov.:
32
AF XY:
0.951
AC XY:
70770
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.982
AC:
40795
AN:
41538
American (AMR)
AF:
0.944
AC:
14410
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.910
AC:
3159
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5170
AN:
5172
South Asian (SAS)
AF:
0.946
AC:
4570
AN:
4830
European-Finnish (FIN)
AF:
0.973
AC:
10326
AN:
10612
Middle Eastern (MID)
AF:
0.853
AC:
249
AN:
292
European-Non Finnish (NFE)
AF:
0.924
AC:
62838
AN:
68006
Other (OTH)
AF:
0.939
AC:
1984
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
392
784
1177
1569
1961
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.935
Hom.:
35634
Bravo
AF:
0.948
Asia WGS
AF:
0.978
AC:
3391
AN:
3466

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Thr2143Thr in exon 53 of OTOGL: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 7.9% (675/8584) of European American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs2717482). -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.34
CADD
Benign
5.9
DANN
Benign
0.67
PhyloP100
0.84
PromoterAI
-0.0016
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2717482; hg19: chr12-80761465; COSMIC: COSV54020811; COSMIC: COSV54020811; API